Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis

  • M. Redlberger-Fritz
  • S. W. Aberle
  • R. Strassl
  • T. Popow-Kraupp


The high mutation rate of influenza virus, combined with the increasing worldwide use of influenza virus-specific drugs, allows the selection of viruses that are resistant to the currently available antiviral medications. Therefore, reliable tests for the rapid detection of drug-resistant influenza virus strains are required. We evaluated the use of a procedure involving real-time polymerase chain reaction (PCR) followed by melting point analysis (MPA) of hybrids formed between the PCR product and a specific oligonucleotide probe for the identification of point mutations in the influenza A virus neuraminidase gene (NA) that are associated with oseltamivir resistance [resulting in the amino acid change H275Y for seasonal and pandemic influenza A(H1N1) viruses and E119V for A(H3N2) viruses]. Therefore, 54 seasonal A(H1N1) (12 oseltamivir-resistant and 42 sensitive strains), 222 A(H1N1)2009 (5 resistant, 217 sensitive), and 51 A(H3N2) viruses (2 resistant, 49 sensitive) were tested by MPA, and the results were compared to those obtained by sequencing the NA gene. The results clearly indicate that the identification of drug resistance mutations by MPA is as accurate as sequencing, irrespective of whether MPA is performed using clinical material or the corresponding isolate. MPA enables a clear identification of mutations associated with antiviral resistance.


  1. 1.
    Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS (2002) Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347(26):2097–2103. doi:10.1056/NEJMoa020546 PubMedCrossRefGoogle Scholar
  2. 2.
    Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA (1997) Influenza virus infections in infants. Pediatr Infect Dis J 16(11):1065–1068PubMedCrossRefGoogle Scholar
  3. 3.
    Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342(4):232–239. doi:10.1056/NEJM200001273420402 PubMedCrossRefGoogle Scholar
  4. 4.
    Sullivan KM, Monto AS, Longini IM Jr (1993) Estimates of the US health impact of influenza. Am J Public Health 83(12):1712–1716PubMedCrossRefGoogle Scholar
  5. 5.
    World Health Organization (WHO) (2005) Influenza fact sheetGoogle Scholar
  6. 6.
    Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG (2001) Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 183(4):523–531. doi:10.1086/318537 PubMedCrossRefGoogle Scholar
  7. 7.
    Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297(13):1435–1442. doi:10.1001/jama.297.13.1435 PubMedCrossRefGoogle Scholar
  8. 8.
    Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S (2007) Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 55(3):267–272. doi:10.1016/j.jinf.2007.05.176 PubMedCrossRefGoogle Scholar
  9. 9.
    Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364(9436):759–765. doi:10.1016/S0140-6736(04)16934-1 PubMedCrossRefGoogle Scholar
  10. 10.
    Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M (2009) Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis 48(4):389–396. doi:10.1086/596311 PubMedCrossRefGoogle Scholar
  11. 11.
    Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007–08. Emerg Infect Dis 15(2):155–162PubMedCrossRefGoogle Scholar
  12. 12.
    Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC (2008) Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill 13(5):pii:8026Google Scholar
  13. 13.
    Wong SS, Yuen KY (2008) Antiviral therapy for respiratory tract infections. Respirology 13(7):950–971. doi:10.1111/j.1440-1843.2008.01404.x PubMedGoogle Scholar
  14. 14.
    Gubareva LV (2004) Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res 103(1–2):199–203. doi:10.1016/j.virusres.2004.02.034 PubMedCrossRefGoogle Scholar
  15. 15.
    Tisdale M (2000) Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors. Rev Med Virol 10(1):45–55. doi:10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R PubMedCrossRefGoogle Scholar
  16. 16.
    Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50(7):2395–2402. doi:10.1128/AAC.01339-05 PubMedCrossRefGoogle Scholar
  17. 17.
    Wetherall NT, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin JL, Zambon M, Hayden FG (2003) Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 41(2):742–750PubMedCrossRefGoogle Scholar
  18. 18.
    Göhring K, Mikeler E, Jahn G, Hamprecht K (2006) Rapid simultaneous detection by real-time PCR of cytomegalovirus UL97 mutations in codons 460 and 520 conferring ganciclovir resistance. J Clin Microbiol 44(12):4541–4544. doi:10.1128/JCM.01141-06 PubMedCrossRefGoogle Scholar
  19. 19.
    Redlberger M, Aberle SW, Heinz FX, Popow-Kraupp T (2007) Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria. Vaccine 25(32):6061–6069. doi:10.1016/j.vaccine.2007.05.045 PubMedCrossRefGoogle Scholar
  20. 20.
    Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC (2004) Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 42(4):1564–1569PubMedCrossRefGoogle Scholar
  21. 21.
    Overduin P, Jenny S, Meijer A (2011) Influenza A PCR Light Cycler - probe test A-matrix-B-NS-H1-H1v-H3-H5-N1-N1v-N1avian-N2. RIVM Laboratory Protocol Library document; https://extranet.ecdc.europa.eu/EISN/Shared%20Documents/Document%20library%20and%20past%20meetings/CNRL%20library/Laboratory%20Protocol%20Library/Molecular%20Detection/Influenza_diagnostic_qPCR_RIVM_2011.pdf
  22. 22.
    World Health Organization (WHO) (2010) WHO External Quality Assessment Programme for the Detection of Influenza Virus Type A by PCR, Summary Report Panel 7 (January–March 2010)Google Scholar
  23. 23.
    Duwe S, Schweiger B (2008) A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Methods 153(2):134–141. doi:10.1016/j.jviromet.2008.07.017 PubMedCrossRefGoogle Scholar
  24. 24.
    Guo L, Garten RJ, Foust AS, Sessions WM, Okomo-Adhiambo M, Gubareva LV, Klimov AI, Xu X (2009) Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay. Antiviral Res 82(1):29–33. doi:10.1016/j.antiviral.2009.01.004 PubMedCrossRefGoogle Scholar
  25. 25.
    Mahony JB, Chong S, Luinstra K, Petrich A, Smieja M (2010) Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses. J Clin Virol 49(4):277–282. doi:10.1016/j.jcv.2010.08.006 PubMedCrossRefGoogle Scholar
  26. 26.
    Wong S, Pabbaraju K, Wong A, Fonseca K, Drews SJ (2011) Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes. J Virol Methods 173(2):259–265. doi:10.1016/j.jviromet.2011.02.014 PubMedCrossRefGoogle Scholar
  27. 27.
    Bolotin S, Robertson AV, Eshaghi A, De Lima C, Lombos E, Chong-King E, Burton L, Mazzulli T, Drews SJ (2009) Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates. J Virol Methods 158(1–2):190–194. doi:10.1016/j.jviromet.2009.01.016 PubMedCrossRefGoogle Scholar
  28. 28.
    Carr MJ, Sayre N, Duffy M, Connell J, Hall WW (2008) Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses. J Virol Methods 153(2):257–262. doi:10.1016/j.jviromet.2008.07.011 PubMedCrossRefGoogle Scholar
  29. 29.
    Operario DJ, Moser MJ, St George K (2010) Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus. J Clin Microbiol 48(10):3517–3524. doi:10.1128/JCM.01031-10 PubMedCrossRefGoogle Scholar
  30. 30.
    van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M (2010) Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol 47(1):34–37. doi:10.1016/j.jcv.2009.09.030 PubMedCrossRefGoogle Scholar
  31. 31.
    Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52(9):3284–3292. doi:10.1128/AAC.00555-08 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • M. Redlberger-Fritz
    • 1
  • S. W. Aberle
    • 1
  • R. Strassl
    • 1
  • T. Popow-Kraupp
    • 1
  1. 1.Department of VirologyMedical University ViennaViennaAustria

Personalised recommendations